News + Events
Resources for right now
The big picture
A closer look
Innovations in Infrastructure
Workforce for the Future
Retail / Consumer Products
Recession’s health repercussions
This article explores how recessions impact health and inhibit system resilience
Global Risks Report 2023
Tougher trade-offs risk eroding climate action, human development and future resilience.
Life support: a people prescription for resilient health systems
This report explores characteristics of resilience at the healthcare system level, factors undermining resilience, and ways forward as healthcare providers emerge from the COVID-19 pandemic.
Pharma's Opportunity to Impact Health Equity
Pharmaceutical companies are uniquely positioned to impact health equity. It must become a corporate priority and engrained in the product life cycle
Health Equity is a Business and Moral Imperative
The message from state and federal regulators is clear: Addressing health equity is no longer a choice for insurers, it is a part of doing business with Medicare and Medicaid
Global insurer survey report: MMB Health trends 2023
Navigating cost trends and using innovation in employer-provided healthcare
What We Now Know About Long COVID – And What To Do About It
Economic Conditions Reshape Private Equity Deal Making
Despite a slowdown in deal making, pharmaceuticals and healthtech continue to get attention from investors.
Health Benefit Cost Growth Will Accelerate to 5.6% in 2023
Healthcare affordability is an issue for many employees, especially with inflation stressing household budgets. Employers are trying to keep more money in employees' paychecks and remove cost barriers when care is needed.
Fulfilling a Legacy of Societal Risk Management
This initiative applies five core insurance sector capabilities to a series of innovative Pioneer Projects that illustrate the power of insurance in risk reduction efforts.
Digital Health Compendium
A selection of perspectives from experts across our businesses on risk, people, and strategy issues at the intersection of transformative technologies and health. The compendium explores opportunities and risks for healthcare and health technology providers, insurers, and employers.
Artificial Intelligence in Life Sciences: An Evolving Risk Landscape
While AI yields tremendous benefits, the technological risks are wide-ranging and complex. This article examines the key risks – and measures to counter them.
Artificial Intelligence: Continuing to revolutionise the life sciences value chain
After years of caution, the life sciences industry is embracing AI innovation and its wealth of opportunities.
Creating the Digitally-Enabled Doctor
Overcoming barriers, and forging early wins, is vital to truly leverage the power of digital health.
AI in Life Sciences: Future-Proofing Strategies
Life sciences businesses must implement robust frameworks to manage AI. Here are the key steps to deploy AI successfully, manage outcomes, and safeguard against risks.
US remains heavily reliant on foreign medicine ingredients
China and India dominate medicine ingredient production, raising concerns over pharmaceutical supply chain resilience.